Vertex Pharmaceuticals reports 7.1% stake in Kymera

Vertex Pharmaceuticals (NASDAQ:VRTX) acquires ~3.15M shares of Kymera Therapeutics (NASDAQ:KYMR), representing 7.1% of its total shares outstanding.

Shares were acquired pursuant to Vertex’s collaboration with Kymera and in a private placement that was closed concurrently with the closing of Kymera’s IPO on August 25, 2020.

Vertex had paid an initial consideration of $70M, including $50M upfront payment and $20M worth equity investment.

Press Release

https://seekingalpha.com/news/3611623-vertex-pharmaceuticals-reports-7_1-stake-in-kymera-therapeutics